Join to View Full Profile
460 W 10th AveColumbus, OH 43210
Phone+1 614-293-6786
Fax+1 614-293-1470
Dr. He is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2012 - 2015
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 2009 - 2012
Peking Union Medical CollegeClass of 1996
Certifications & Licensure
OH State Medical License 2016 - 2026
MD State Medical License 2013 - 2016
Clinical Trials
- A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors Start of enrollment: 2020 Aug 17
Roles: Principal Investigator
Publications & Presentations
PubMed
- Evaluating the effect of immune checkpoint inhibitor treatment on chronic obstructive pulmonary disease in lung cancer patients.Anet Greib, Songzhu Zhao, Michelle Ploch, Jonathan Henricks, Robert Easterling
Oncoimmunology. 2025-12-01 - Trends in Mesothelioma Mortality in the United States Between 1999 and 2020.Alexander J Didier, Mingjia Li, Jinesh Gheeya, Asrar Alahmadi, Jacob Kaufman
JTO Clinical and Research Reports. 2025-05-01 - CLO25-053: Real-World Evidence of Survival in Patients With Metastatic NSCLC Treated With First-Line Immune Checkpoint Inhibitors Beyond Progression.Natalie Johns, Alexander Rudich, Songzhu Zhao, Kenneth Chian, Po-Lan Su
Journal of the National Comprehensive Cancer Network. 2025-03-28
Journal Articles
- Identifying Patterns of Care for Elderly Patients with Non-Surgically Treated Stage III Non-Small Cell Lung Cancer: An Analysis of the National Cancer DatabaseKai He, Terence M Williams, John C Grecula, Eric D Miller, Erin M Bertino, David P Carbone, Peter G Shields, Jose G Bazan, Karl E Haglund, Gregory A Otterson, BioMed Central
- Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens from Patients with Lung AdenocarcinomaKai He, MD, Clinical Lung Cancer
Press Mentions
Could a Dissolving Implant Revolutionize How We Manage Pain?July 8th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
